2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorderRecruitingPhase 1 / Phase 22026-07-21NCT06649110
A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILDPathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorderActive, not recruitingPhase 32026-04-01NCT04691154